지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.3
- 수록면
- 4 - 13 (10page)
- DOI
- 10.17998/jlc.2022.01.16
이용수
초록· 키워드
오류제보하기
Transarterial radioembolization (TARE) with yttrium 90 (90Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea. There are two types of 90Y radioactive microspheres available, namely, glass and resin microspheres, with comparable clinical outcomes. In general, TARE outperforms transarterial chemoembolization regarding post-embolization syndrome, time to progression, tumor downsizing for liver transplantation, and hospitalization stay. Although TARE is commonly recommended for patients with unresectable large HCCs, it can be an alternative to or performed in combination with ablation, surgical resection, and systemic treatment. This review aimed to address 90Y radioactive microspheres, patient selection, clinical outcomes, simulation tests, radioembolization procedures, follow-up imaging, and complications.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
Journal of Liver Cancer
2020 .01
-
Bridging and Downstaging Role of Transarterial Radioembolization (TARE) for Expected Small Remnant Volume after Liver Resection in Hepatocellular Carcinoma
대한외과학회 학술대회 초록집
2018 .11
-
Hepatocellular Carcinoma with Segmental Portal Vein Invasion Exhibiting a Complete Response after Transarterial Radioembolization
Journal of Liver Cancer
2019 .01
-
Superselective transarterial radioembolization for the treatment of hepatocellular carcinoma
International Journal of Gastrointestinal Intervention
2021 .10
-
Concurrent transarterial radioembolization and combination atezolizumab/bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
Journal of Liver Cancer
2022 .03
-
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization
Journal of Liver Cancer
2021 .01
-
Selecting the Right Tool for the Right Job: Which Response Criteria Better Predicts Survival of Patients Treated with Transarterial Radioembolization?
Gut and Liver
2020 .01
-
Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Management of Hepatocellular Carcinoma: Current Status and Future Directions
Gut and Liver
2015 .01
-
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
Gut and Liver
2020 .01
-
Radiation segmentectomy for gastric leiomyosarcoma hepatic metastasis
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2018 .12
-
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Hong Kong perspective
Clinical and Molecular Hepatology
2023 .04
-
Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for the Treatment of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Current Trends and Recent Advances in Diagnosis, Therapy, and Prevention of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Clinical and Molecular Hepatology
2018 .01
-
Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
Journal of Liver Cancer
2020 .01
-
Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry
Journal of Liver Cancer
2020 .01
-
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
Clinical and Molecular Hepatology
2023 .04
-
Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy
Journal of Liver Cancer
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0